160 related articles for article (PubMed ID: 34252869)
1. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
[TBL] [Abstract][Full Text] [Related]
2. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues.
Hu H; Xu XQ; Chen L; Chen W; Wu Q; Chen HH; Zhu H; Shi HB; Wu FY
Endocrine; 2020 Nov; 70(2):372-379. PubMed ID: 32504380
[TBL] [Abstract][Full Text] [Related]
3. T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy.
Zhai L; Wang Q; Liu P; Luo B; Yuan G; Zhang J
Korean J Radiol; 2022 Jun; 23(6):664-673. PubMed ID: 35555881
[TBL] [Abstract][Full Text] [Related]
4. T2 mapping histogram at extraocular muscles for predicting the response to glucocorticoid therapy in patients with thyroid-associated ophthalmopathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Xu XQ; Shi HB; Wu FY
Clin Radiol; 2021 Feb; 76(2):159.e1-159.e8. PubMed ID: 33010933
[TBL] [Abstract][Full Text] [Related]
5. Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
Liu P; Luo B; Chen L; Wang QX; Yuan G; Jiang GH; Zhang J
Front Endocrinol (Lausanne); 2021; 12():614536. PubMed ID: 33716970
[TBL] [Abstract][Full Text] [Related]
6. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ
Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397
[TBL] [Abstract][Full Text] [Related]
8. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.
Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S
Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229
[No Abstract] [Full Text] [Related]
9. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
[TBL] [Abstract][Full Text] [Related]
10. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
11. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
12. T
Hu H; Chen L; Zhang JL; Chen W; Chen HH; Liu H; Shi HB; Wu FY; Xu XQ
J Magn Reson Imaging; 2022 Sep; 56(3):862-872. PubMed ID: 35092642
[TBL] [Abstract][Full Text] [Related]
13. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.
Wang YY; Wu Q; Chen L; Chen W; Yang T; Xu XQ; Wu FY; Hu H; Chen HH
Endocr Connect; 2021 Jun; 10(7):676-684. PubMed ID: 34077388
[TBL] [Abstract][Full Text] [Related]
15. Role of Peripheral Regulatory T Lymphocytes in Patients with Thyroid Associated Ophthalmopathy During Systemic Glucocorticoid Treatment: A Prospective Observational Study.
Xu QQ; Zhang XL; Luo B; Li T; Yuan G; Shao SY
Curr Med Sci; 2023 Feb; 43(1):130-138. PubMed ID: 36459302
[TBL] [Abstract][Full Text] [Related]
16. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods.
Chen W; Hu H; Chen HH; Su GY; Yang T; Xu XQ; Wu FY
Acta Radiol; 2020 Nov; 61(11):1512-1519. PubMed ID: 32053002
[TBL] [Abstract][Full Text] [Related]
17. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K
Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
[TBL] [Abstract][Full Text] [Related]
18. T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy.
Li H; Wang B; Li Q; Li Q; Qiao J; Lin D; Sui C; Ye L; Zhai H; Jiang B; Wang N; Han B; Jiang M; Tao X; Shao Z; Zhu C; Ma Y; Xiong P; Sun J; Zhou H; Lu Y
Endocr Res; 2023 Jul; 48(2-3):55-67. PubMed ID: 37345481
[TBL] [Abstract][Full Text] [Related]
19. Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
Zhang H; Hu H; Wang Y; Duan X; Chen L; Zhou J; Chen W; Zhang W; Xu X; Chen H
Eur Thyroid J; 2024 Feb; 13(1):. PubMed ID: 38236726
[TBL] [Abstract][Full Text] [Related]
20. A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy.
Wang Y; Zhang S; Zhang Y; Liu X; Gu H; Zhong S; Huang Y; Fang S; Sun J; Zhou H; Fan X
BMC Endocr Disord; 2018 Feb; 18(1):13. PubMed ID: 29463244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
